Provided by Tiger Fintech (Singapore) Pte. Ltd.

I-MAB

2.31
+0.299314.89%
Volume:42.49M
Turnover:123.50M
Market Cap:188.58M
PE:-20.74
High:3.44
Open:2.26
Low:2.25
Close:2.01
Loading ...

Top Midday Gainers

MT Newswires Live
·
1 hour ago

I-Mab Prices $65 Million Offering of American Depositary Shares

MT Newswires Live
·
Yesterday

Everest Medicines Ltd. Expands Stake with $30.9 Million Investment in U.S.-Based Biotech Firm I-Mab

Reuters
·
Yesterday

I-Mab prices 33.3M ADSs at $1.95 in underwritten offering

TIPRANKS
·
Yesterday

I-Mab Announces Pricing of $65 Million Underwritten Offering of American Depositary Shares

GlobeNewswire
·
Yesterday

I-MAB Announces Preliminary Financial Results for Mid-2025

TIPRANKS
·
Yesterday

BRIEF-I-Mab Strengthens Givastomig Intellectual Property Portfolio Through Acquisition Of Bridge Health

Reuters
·
17 Jul

I-Mab to Acquire Bridge Health Biotech

MT Newswires Live
·
17 Jul

I-Mab entered into agreement to acquire 100% ownership of Bridge Health Biotech

TIPRANKS
·
17 Jul

I-Mab Announces Phase 1b Dose Expansion Progress for Givastomig, Anticipates Topline Readout in Q1 2026

Reuters
·
17 Jul

I-Mab to Present at the BTIG Virtual Biotechnology Conference

GlobeNewswire
·
14 Jul

I-MAB Amends Prospectus for $21 Million ADS Offering

TIPRANKS
·
12 Jul

I-Mab Price Target Maintained With a $5.00/Share by Needham

Dow Jones
·
09 Jul

I-MAB’s Givastomig Shows Promising Efficacy and Safety in Gastric Cancer, Earning Buy Rating

TIPRANKS
·
09 Jul

I-Mab Unveils Corporate Presentation Highlighting Innovative Drug Development and Promising Cancer Therapies

Reuters
·
03 Jul

I-Mab presents Gibastomig Phase 1b dose escalation data

TIPRANKS
·
02 Jul

I-Mab to Present Positive Phase 1b Givastomig Data at ESMO GI 2025

Reuters
·
02 Jul

I-Mab publishes givastomig monotherapy data in Clinical Cancer Research

TIPRANKS
·
01 Jul

I-Mab Is Maintained at Buy by Needham

Dow Jones
·
27 Jun

Promising Clinical Data and Rapid Enrollment Propel I-MAB’s Givastomig to a Buy Rating

TIPRANKS
·
27 Jun